Anavex Life Sciences (AVXL)
(Delayed Data from NSDQ)
$10.97 USD
+0.08 (0.73%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $10.97 0.00 (0.00%) 7:04 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Anavex Life Sciences Corp.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
AVXL 10.97 +0.08(0.73%)
Will AVXL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AVXL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVXL
Are You Looking for a Top Momentum Pick? Why Anavex Life Sciences (AVXL) is a Great Choice
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
AVXL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus
Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why
Best Momentum Stocks to Buy for January 21st
Other News for AVXL
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August ...
Anavex Life Sciences (AVXL) Maintains 'Buy' Rating with $46 Target | AVXL Stock News
Anavex (AVXL) Reveals Promising Data for Alzheimer's Treatment
Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral ...
Anavex announces precision medicine results of oral blarcamesine treatment